Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Endocrinology

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-09-1020PMID 20071479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One‐year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements

  2009cited by this paper
• Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis

  2009cited by this paper
• Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

  2009cited by this paper
• Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia

  2009cited by this paper
• Continuous Glucose Monitoring System in the Screening of Early Glucose Derangements in Children and Adolescents with Cystic Fibrosis

  2008cited by this paper
• Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007.

  2008cited by this paper
• No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.

  2008cited by this paper
• Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.

  2008cited by this paper
• Management of cystic fibrosis‐related diabetes

  2008cited by this paper
• Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance

  2008cited by this paper
• Standards of Medical Care in Diabetes—2008

  2008cited by this paper
• Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.

  2007cited by this paper
• Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance

  2006cited by this paper
• Epidemiology of cystic fibrosis-related diabetes.

  2005cited by this paper
• Continuous glucose monitoring in adolescents with cystic fibrosis.

  2005cited by this paper
• Conventional measures underestimate glycaemia in cystic fibrosis patients

  2004cited by this paper
• Status of research funded by the American Diabetes Association--year 4.

  2003cited by this paper
• Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis.

  2003cited by this paper
• Status of research funded by the American Diabetes Association--year 4.

  2003cited by this paper
• Predictors of deterioration of lung function in cystic fibrosis *

  2002cited by this paper
• Clinical improvement in cystic fibrosis with early insulin treatment

  2002cited by this paper
• The MiniMed Continuous Glucose Monitoring System

  2000cited by this paper
• HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.

  2000cited by this paper
• Joining together to combat poverty. Everybody welcome and needed.

  2000cited by this paper
• Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline.

  2000cited by this paper
• Establishing a standard definition for child overweight and obesity worldwide: international survey

  2000cited by this paper
• Joining together to combat poverty: everybody welcome and needed

  2000cited by this paper
• The MiniMed Continuous Glucose Monitoring System (CGMS).

  1999cited by this paper
• Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

  1999cited by this paper
• Abnormal glucose metabolism in cystic fibrosis.

  1998cited by this paper
• Glucose tolerance in patients with cystic fibrosis: five year prospective study

  1995cited by this paper
• Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

  1994cited by this paper
• Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function

  1993cited by this paper
• Diabetes mellitus in cystic fibrosis: genetic and immunological markers

  1993cited by this paper

• The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review

  2026cites this paper
• Use of Continuous Glucose Monitoring for Detecting and Understanding Early Dysglycemia in Cystic Fibrosis.

  2026cites this paper
• Utility of Continuous Glucose Monitors for Improved Detection of Cystic Fibrosis‐Related Diabetes

  2025cites this paper
• Lab-created conductive filament based on nickel and graphite particles: An attractive material for the additive manufacture of enhanced electrochemical sensors for non-enzymatic and selective glucose sensing.

  2025cites this paper
• Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.

  2025cites this paper
• Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

  2025cites this paper
• Glycemic Variability and the Thickness of Retinal Layers in Cystic Fibrosis Patients with and without Cystic Fibrosis Related Diabetes

  2024cites this paper
• Advances in diabetes technology to improve the lives of people with cystic fibrosis

  2024cites this paper
• The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis

  2024cites this paper
• Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response

  2023cites this paper
• Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.

  2023cites this paper
• Dépistage des anomalies de la tolérance au glucose et du diabète de mucoviscidose. Position de la Société française de la mucoviscidose (SFM), de la Société francophone du diabète (SFD) et de la Société française d’endocrinologie et diabétologie pédiatrique (SFEDP)

  2023cites this paper
• Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis.

  2022cites this paper
• Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review

  2022influential citation
• The Potential Causes of Cystic Fibrosis-Related Diabetes

  2021cites this paper
• Screening Methods for Diagnosing Cystic Fibrosis-Related Diabetes: A Network Meta-Analysis of Diagnostic Accuracy Studies

  2021influential citation
• Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis

  2021cites this paper
• Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis

  2021cites this paper
• Alteraciones del metabolismo hidrocarbonado en niños y adolescentes afectos de fibrosis quística

  2021cites this paper
• Full The Relationship between Continuous Glucose Monitoring and OGTT in Youth and Young Adults with Cystic Fibrosis.

  2021cites this paper
• Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control

  2020cites this paper
• Significance of nanomaterials in electrochemical glucose sensors: An updated review (2016-2020).

  2020cites this paper
• Detection and Management of Early Glucose Abnormalities in Cystic Fibrosis

  2020cites this paper
• Dietary Patterns in New Zealand Women: Evaluating Differences in Body Composition and Metabolic Biomarkers

  2019cites this paper
• Continuous glucose monitoring in cystic fibrosis - A practical guide.

  2019cites this paper
• Dietary recommendations in cystic fibrosis related diabetes

  2019cites this paper
• Ontwikkelingen in het diagnosticeren en behandelen van CF-gerelateerde diabetes (CFRD)

  2019cites this paper
• Unique challenges of cystic fibrosis‐related diabetes

  2018cites this paper
• Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.

  2018cites this paper
• Chapter 2 Cystic Fibrosis – Related Diabetes

  2018influential citation
• Adres do korespondencji

  2018cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis‐related diabetes in children and adolescents

  2018cites this paper
• Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis.

  2018cites this paper
• Glucose intolerance in children with cystic fibrosis: a developing country’s perspective

  2018cites this paper
• Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with β‐thalassemia major

  2018cites this paper
• Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.

  2018cites this paper
• Continuous glucose monitoring systems for the diagnosis of cystic fibrosis‐related diabetes

  2018cites this paper
• Cystic Fibrosis Related Diabetes

  2017cites this paper
• Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes

  2017cites this paper
• Symposium Summaries

  2017cites this paper
• OTHER SPECIFIC TYPES OF DIABETES

  2017cites this paper
• CF‐related diabetes: Containing the metabolic miscreant of cystic fibrosis

  2017cites this paper
• Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?

  2017cites this paper
• Clinical Use of Continuous Glucose Monitoring in Pediatrics

  2017cites this paper
• Diagnosing cystic fibrosis-related diabetes: current methods and challenges

  2016cites this paper
• Sugar Substitute?

  2016cites this paper
• Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes

  2016cites this paper
• Insulin deficiency and cystic fibrosis–related diabetes

  2015cites this paper
• The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.

  2015cites this paper
• Les fluctuations glycémiques et l'inflammation dans le diabète secondaire à la fibrose kystique

  2015cites this paper
• Insulin, Body Mass, and Growth in Young Cystic Fibrosis Patients

  2015cites this paper
• Cystic fibrosis-related diabetes: links, challenges, and future directions

  2015cites this paper
• Cystic Fibrosis–Related Diabetes

  2015cites this paper
• Gastrointestinal disease in cystic fibrosis

  2015cites this paper
• UP-TO-DATE MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS IN CYSTIC FIBROSIS AND TRANSITION OF ADOLESCENTS FROM PEDIATRIC TO ADULT CARE

  2015cites this paper
• Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)

  2014cites this paper
• Therapeutic Use and Diagnostic Potential of Continuous Glucose Monitoring Systems (CGMS) in Adolescents

  2014cites this paper
• Management of cystic fibrosis‐related diabetes in children and adolescents

  2014cites this paper
• Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups

  2014cites this paper
• The screening and diagnosis of cystic fibrosis-related diabetes in the United Kingdom.

  2014cites this paper
• Australian standards of care for cystic fibrosis‐related diabetes

  2014cites this paper
• Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.

  2014cites this paper
• Prognostic Accuracy of Continuous Glucose Monitoring in the Prediction of Diabetes Mellitus in Children with Incidental Hyperglycemia: Receiver Operating Characteristic Analysis

  2013cites this paper
• Continuous Glucose Monitoring: Current Use and Future Directions

  2013cites this paper
• Continuous monitoring blood glucose level in clinical practice and new methods for its analysis

  2013cites this paper
• Abnormal Glycemic Profiles by CGMS in Obese First-Degree Relatives of Type 2 Diabetes Mellitus Patients

  2013cites this paper
• Increased Glycemic Variability at the Onset and During Progression of Type 2 Diabetes—Commentary

  2013cites this paper
• P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom

  2012cites this paper
• 53 – Nonpulmonary Manifestations of Cystic Fibrosis

  2012cites this paper
• Evaluation of long-term glucose homeostasis in lean and obese cats by use of continuous glucose monitoring.

  2012cites this paper
• Low Glycaemic Index Dietary Interventions in Youth with Cystic Fibrosis: A Systematic Review and Discussion of the Clinical Implications

  2012cites this paper
• Continuous glucose monitoring in 2010.

  2011cites this paper
• Cystic Fibrosis Related Diabetes (CFRD)—The End Stage of Progressive Insulin Deficiency

  2011cites this paper
• Management of cystic fibrosis‐related diabetes in children and adolescents

  2009cites this paper